Cure CASK USA - Angelina CASK Neurological Research Foundation mission is to Improve the lives of individuals with CASK gene mutations through research, advocacy, and community connection. ACNRF Vision is to advance innovations in medical research related to nature, diagnosis, prevention and treatment of CASK gene mutations and related conditions. To advance innovations in medical research related
to nature, diagnosis, prevention and treatment of the CASK (calcium/calmodulin-dependent serine protein kinase) mutations, including but not limited to:
(i) The development of a cure for the condition and associated conditions relevant to CASK including microcephaly, agenesis of the corpus callosum, x-linked intellectual disability, disproportionate pontine and cerebellar hypoplasia;
(ii) The development of gene therapy, for patients diagnosed with CASK and associated conditions including but not limited to microcephaly, agenesis of the corpus callosum, x-linked intellectual disability, disproportionate pontine and cerebellar hypoplasia;
(iii) The development of treatments and therapies that may improve quality of life for patients with CASK and associated conditions;
(iv) The development of treatments and therapies that may halt and/or reverse the progressive degenerative conditions associations with the CASK gene mutation;
(v) The development of an electronic library to advance medical research into CASK and its association conditions by developing and maintaining a data base relevant to such research.
2. Develop and maintain clear, accurate and up to date information to assist in patient diagnosis.
3. Distribution of information to assist CASK diagnosed patients and their families to access contemporary innovative CASK research programs and therapies.
4. To raise awareness of this disease (CASK) amongst the community at all levels including but not limited to the medical profession, and public and private sectors.
5. To become an ambassador for innovation in the medical research with the objective of developing productive and sustainable relationships with both the public and private sectors in developing a cure for Cask.
6. To develop best practices in the medical research of the CASK mutation so as to improve the quality of life of patients diagnosed with the condition.
7. To attract enthusiastic, talented and professional research board members from both the public and private sectors to facilitate the governance of the Foundation in the context of medical research with the objective of being at the forefront in the development of a cure for CASK.
8.